Sentante is a medical device company that develops robotic teleoperated systems for endovascular procedures.
Sentante has raised $6.6M in total funding. The most recent round was Seed. The last funding was announced in December 2023.
Sentante's investors include European Innovation Council, Practica Capital, MedTech Innovator.
Sentante is headquartered in Kaunas, Lithuania.
Sentante is a medical device company that develops robotic teleoperated systems for endovascular procedures.
Sentante is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sentante — Funding & Investors." VCBacked, December 21, 2023, https://www.vcbacked.co/company/sentante. Accessed July 19, 2026.
VCBacked. (2023). Sentante — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/sentante
{{cite web |title=Sentante — Funding & Investors |url=https://www.vcbacked.co/company/sentante |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated